ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,303.27
      0.12%
      US Tech 100
      18,062.00
      -0.10%
      Dow Jones
      40,003.59
      0.34%
      Brent Oil
      83.76
      0.00%
      Bitcoin
      66,173.47
      -1.15%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NYSE
      6. ADC Therapeutics SA (ADCT)

      7. ADC Therapeutics SA (ADCT) News

      ADCT

      ADC Therapeutics (ADCT)

      ADC Therapeutics SA
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NYSE:ADCT
      DateTimeSourceHeadlineSymbolCompany
      05/15/20247:15AMGlobeNewswire Inc.ADC Therapeutics to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQNYSE:ADCTADC Therapeutics SA
      05/14/202412:32PMEdgar (US Regulatory)Form 8-K - Current reportNYSE:ADCTADC Therapeutics SA
      05/09/20244:06PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ADCTADC Therapeutics SA
      05/09/20247:15AMGlobeNewswire Inc.ADC Therapeutics to Participate in 2024 RBC Capital Markets Global Healthcare ConferenceNYSE:ADCTADC Therapeutics SA
      05/08/20244:07PMEdgar (US Regulatory)Form 8-K - Current reportNYSE:ADCTADC Therapeutics SA
      05/07/20244:06PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:ADCTADC Therapeutics SA
      05/07/20244:02PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NYSE:ADCTADC Therapeutics SA
      05/06/20247:30AMGlobeNewswire Inc.ADC Therapeutics Announces $105 Million Underwritten Offering of Common Shares and Pre-Funded WarrantsNYSE:ADCTADC Therapeutics SA
      05/06/20246:51AMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NYSE:ADCTADC Therapeutics SA
      05/06/20246:38AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:ADCTADC Therapeutics SA
      05/06/20246:29AMEdgar (US Regulatory)Form 8-K - Current reportNYSE:ADCTADC Therapeutics SA
      05/06/20246:10AMGlobeNewswire Inc.ADC Therapeutics Reports First Quarter 2024 Financial Results and Provides Business UpdatesNYSE:ADCTADC Therapeutics SA
      05/06/20246:00AMGlobeNewswire Inc.ADC Therapeutics Announces Initial Data from Investigator-Initiated Phase 2 Clinical Trial of ZYNLONTA® in Patients with Relapsed/Refractory Marginal Zone LymphomaNYSE:ADCTADC Therapeutics SA
      05/01/20244:05PMGlobeNewswire Inc.ADC Therapeutics Makes Grants to New Employees Under Inducement PlanNYSE:ADCTADC Therapeutics SA
      05/01/20247:00AMGlobeNewswire Inc.ADC Therapeutics to Host First Quarter 2024 Financial Results and Pipeline Update Conference Call on May 6, 2024NYSE:ADCTADC Therapeutics SA
      04/04/20247:00AMGlobeNewswire Inc.ADC Therapeutics Announces Updates on LOTIS-7 Clinical Trial Evaluating ZYNLONTA® in Combination with Glofitamab or Mosunetuzumab in Patients with Relapsed/Refractory B-cell Non-Hodgkin LymphomaNYSE:ADCTADC Therapeutics SA
      04/03/20247:00AMGlobeNewswire Inc.ADC Therapeutics to Host a Virtual Research Investor Event on Tuesday, April 9, 2024NYSE:ADCTADC Therapeutics SA
      04/01/20244:05PMGlobeNewswire Inc.ADC Therapeutics Makes Grants to New Employees Under Inducement PlanNYSE:ADCTADC Therapeutics SA
      03/13/20247:03AMIH Market NewsMixed Futures Amidst Quiet Economic Schedule; Oil Prices ClimbNYSE:ADCTADC Therapeutics SA
      03/13/20247:00AMGlobeNewswire Inc.ADC Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdatesNYSE:ADCTADC Therapeutics SA
      03/06/20247:15AMGlobeNewswire Inc.ADC Therapeutics to Participate in the Guggenheim 5th Annual Healthy Altitudes SummitNYSE:ADCTADC Therapeutics SA
      03/06/20247:00AMGlobeNewswire Inc.ADC Therapeutics to Host Fourth Quarter and Year-End 2023 Financial Results Conference Call on March 13, 2024NYSE:ADCTADC Therapeutics SA
      03/05/20245:45PMGlobeNewswire Inc.ADC Therapeutics Announces Abstracts Accepted for Presentation at the American Association for Cancer Research (AACR) Annual MeetingNYSE:ADCTADC Therapeutics SA
      03/05/20249:15AMEdgar (US Regulatory)Form 8-K - Current reportNYSE:ADCTADC Therapeutics SA
      02/29/20244:30PMEdgar (US Regulatory)Form 8-K - Current reportNYSE:ADCTADC Therapeutics SA
      02/27/20247:00AMGlobeNewswire Inc.ADC Therapeutics to Participate in the TD Cowen 44th Annual Health Care ConferenceNYSE:ADCTADC Therapeutics SA
      01/24/20248:00AMEdgar (US Regulatory)Form 8-K - Current reportNYSE:ADCTADC Therapeutics SA
      01/19/20244:30PMEdgar (US Regulatory)Form 8-K - Current reportNYSE:ADCTADC Therapeutics SA
      01/04/20247:15AMEdgar (US Regulatory)Form 8-K - Current reportNYSE:ADCTADC Therapeutics SA
      01/04/20247:15AMGlobeNewswire Inc.ADC Therapeutics Regains Compliance with NYSE Continued Listing StandardsNYSE:ADCTADC Therapeutics SA
       Showing the most relevant articles for your search:NYSE:ADCT